Javascript must be enabled to continue!
DESIGN AN “IN-HOUSE” SOFTWARE FOR CALCULATING THE RISK OF TRISOMY 21, TRISOMY 18 AND OPEN NEURAL TUBE DEFECTS IN THE GESTATIONAL AGED 15 – 22 WEEKS
View through CrossRef
Objectives: Design an “in-house” software for calculating the risk of fetus has Down syndrome, Edwards syndrome and open neural tube defects in prenatal screening at the gestational aged 15-22. Methods: Based on the Excel program of Microsoft Office and the articles with the Excel of Microsoft Office and related published articles, we design an “in-house” software based on maternal age, gestational age, history of having children with chromosomal aberrations and adjusted maternal serum markers AFP, hCG and uE3. The results were compared with the results of Prisca software by non-parametric method. Results: In cases having the risk of trisomy 21 with the range from 1/251 to 1/350: the risk tends to be lower than Prisca (83.7%). In cases having the high risks of trisomy 21 in screening but the results of prenatal diagnosis are not trisomy: the risks of “in house” software are lower than the risks of Prisca (73%) with 29% of cases has the risks less than 1/250 . In cases of trisomy 18 with the risks are lower than 1/150: there are no statistical significant differences between the two softwares (P<0.05). In screening open neural tube defects, the cases have the threshold higher than 1.50 MoM AFP: The results in the “in house” software tend to higher than Prisca (94%). The cases have the threshold lower than 1.50 MoM AFP: Where the disability screening of neural tube openings with thresholds lower than 1.5 MoM AFP: there are no statistical significant differences between the two softwares (P<0.05). Conclusion: The “in house” software has all the necessary functions for calculating the risk of Down syndrome, Edwards syndrome and open neural tube at the gestational aged 15-22.
Title: DESIGN AN “IN-HOUSE” SOFTWARE FOR CALCULATING THE RISK OF TRISOMY 21, TRISOMY 18 AND OPEN NEURAL TUBE DEFECTS IN THE GESTATIONAL AGED 15 – 22 WEEKS
Description:
Objectives: Design an “in-house” software for calculating the risk of fetus has Down syndrome, Edwards syndrome and open neural tube defects in prenatal screening at the gestational aged 15-22.
Methods: Based on the Excel program of Microsoft Office and the articles with the Excel of Microsoft Office and related published articles, we design an “in-house” software based on maternal age, gestational age, history of having children with chromosomal aberrations and adjusted maternal serum markers AFP, hCG and uE3.
The results were compared with the results of Prisca software by non-parametric method.
Results: In cases having the risk of trisomy 21 with the range from 1/251 to 1/350: the risk tends to be lower than Prisca (83.
7%).
In cases having the high risks of trisomy 21 in screening but the results of prenatal diagnosis are not trisomy: the risks of “in house” software are lower than the risks of Prisca (73%) with 29% of cases has the risks less than 1/250 .
In cases of trisomy 18 with the risks are lower than 1/150: there are no statistical significant differences between the two softwares (P<0.
05).
In screening open neural tube defects, the cases have the threshold higher than 1.
50 MoM AFP: The results in the “in house” software tend to higher than Prisca (94%).
The cases have the threshold lower than 1.
50 MoM AFP: Where the disability screening of neural tube openings with thresholds lower than 1.
5 MoM AFP: there are no statistical significant differences between the two softwares (P<0.
05).
Conclusion: The “in house” software has all the necessary functions for calculating the risk of Down syndrome, Edwards syndrome and open neural tube at the gestational aged 15-22.
Related Results
Prevalence of Neural tube defects at PUMHS Hospital.
Prevalence of Neural tube defects at PUMHS Hospital.
Introduction: Spina bifida, anencephaly, and encephalocele are neural tube defects (NTD) and result from failure of closure of the neural tube between 21and 28 days following conce...
Clinical and molecular genetic characterization of two siblings with trisomy 2p24.3‐pter and monosomy 5p14.3‐pter
Clinical and molecular genetic characterization of two siblings with trisomy 2p24.3‐pter and monosomy 5p14.3‐pter
Partial trisomy 2p syndrome is occasionally associated with neural tube defects (NTDs), such as anencephaly, encephalocele, and spina bifida, in addition to common features of inte...
Related Factors For Preterm Birth in Twins After Single Intrauterine Death:a case control study
Related Factors For Preterm Birth in Twins After Single Intrauterine Death:a case control study
Abstract
Background Single intrauterine death in twin pregnancy has become a relatively frequent complication of twin pregnancy. Preterm delivery is one of the complication...
Tube Shunt Related Complications in Pediatrics
Tube Shunt Related Complications in Pediatrics
Although medical therapy is usually an excellent therapeutic option in the adult population, in children it is often ineffective or associated with an undesirable risk:benefit rati...
Pcgf1 regulates early neural tube development through histone methylation in zebrafish
Pcgf1 regulates early neural tube development through histone methylation in zebrafish
Abstract
Objective
Early neural tube development in the embryo includes neural induction and self-renewal of neural stem cells (NSCs). The abnormal of neural tube developm...
Systematic evaluation of NIPT aneuploidy detection software tools with clinically validated NIPT samples
Systematic evaluation of NIPT aneuploidy detection software tools with clinically validated NIPT samples
AbstractMotivationNon-invasive prenatal testing (NIPT) is a powerful screening method for fetal aneuploidy detection, relying on laboratory and computational analysis of cell-free ...
Gestational Trophoblastic Disease and Gestational Trophoblastic Neoplasm - An Experience at Tertiary Care Hospital
Gestational Trophoblastic Disease and Gestational Trophoblastic Neoplasm - An Experience at Tertiary Care Hospital
Objective: To determine the frequency of gestational trophoblastic diseases and gestational tropho- blastic neoplasm, its risk factors and prognosis.
Methods: This was a de...

